Tag Archives: NASDAQ

Notable Gainer on Friday: Dataram Corporation (DRAM)

On September 22, 2011, Dataram Corporation (NASDAQ:DRAM) selected Dell OEM Solutions to deliver data storage optimization to marketplace. The Company on Thursday announced the selection of Dell OEM solutions to manufacture, distribute, and provide support for the Dataram XcelaSAN storage … Continue reading

Posted in Around the Market, Contributors | Tagged , , , , | 1 Comment

Schnitzer Steel Industries Reports 1Q Results, Shares Flat

Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) gained 0.21% to $43.79 in the morning hour after the company reported fiscal first-quarter profit which fell 61% as the company witnessed a sharp slowdown in demand, mainly due to the European debt crisis. The … Continue reading

Posted in Around the Market, Contributors | Tagged , , , , | Leave a comment

American Medical Alert (NASDAQ: AMAC) Was The Biggest gainer On NASDAQ

On September23, 2011, Shares of American Medical Alert (NASDAQ:AMAC) surged more than 47% on $82.3 million buyout offer from UK-based Tunstall Healthcare Group, a leading telehealth and telecare provider. The Company announced on Friday that it has entered into a … Continue reading

Posted in Around the Market, Contributors | Tagged , , , , | 2 Comments

ZOLL Medical Disclosed That LifeVest Defibrillator Will Still Be Covered By Medicare

ZOLL Medical Corporation (NASDAQ: ZOLL) disclosure that the Centers for Medicare & Medicaid Services said it will continue to cover the company’s wearable LifeVest defibrillator. The company’s LifeVest wearable defibrillator is worn by patients at risk for sudden cardiac arrest. … Continue reading

Posted in Around the Market, Contributors | Tagged , , , , | Leave a comment

Bio-Reference Laboratories 4Q Profit Rises; Tops Estimate

Bio-Reference Laboratories, Inc.  (NASDAQ: BRLI) reported a better-than-expected increase in fourth-quarter profit on double-digit top line growth. The company reported fourth-quarter net profit of $10.5 million or $0.37 per share, as compared to $8.6 million or $0.31 per share a year … Continue reading

Posted in Around the Market, Contributors | Tagged , , , | Leave a comment

Abraxas Petroleum Corp. (NASDAQ: AXAS) Gains trading momentum with other energy stocks

Abraxas Petroleum Corp. (NASDAQ:AXAS) shares had moved up 28% in the day’s trading with the trading range being $2.60-$3.29. Shares of the independent energy company leaded the Oil and Gas operations stocks rallying 28.02% while hitting the day’s high of $3.29. Trading of … Continue reading

Posted in Around the Market, Contributors | Tagged , , , , | Leave a comment

Ulta Salon, Cosmetics & Fragrance (ULTA) Shares Soar Following Solid Earnings

Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA) gained 6.44 % to $72.90 in the morning hours after the company announced financial results for the third quarter and first nine months ended October 29, 2011, which compares to the same … Continue reading

Posted in Around the Market, Contributors | Tagged , , , , | Leave a comment

Semtech Corporation Gains On Results;Provides Outlook

Semtech Corporation (NASDAQ: SMTC) increased 4.44% to $24.23 in the morning hours after the company’s third-quarter earnings rose 68% as revenue edged up from a year-ago period hurt by higher charges. For the quarter ended Oct. 30, the company reported … Continue reading

Posted in Around the Market, Contributors | Tagged , , , | Leave a comment

Uranium Resources Announces Start of Phase II Drilling

Uranium Resources, Inc. (NASDAQ: URRE) announced today that Cameco Resources (“Cameco”) has elected to move forward with Phase II of the three phase exploratory program on the 54,847 acres in Kenedy County, Texas, known as the “Los Finados Project.” The … Continue reading

Posted in Around the Market, Contributors | Tagged , , , | Leave a comment

Onyx Pharmaceuticals Exploring Options Of Potential Sale, Shares Soar

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), known for its liver cancer drug Nexavar, jumped more than 13% on Monday, after Bloomberg reported the company was exploring options, including a possible sale. Potential buyers are studying Onyx’s business and its experimental carfilzomib … Continue reading

Posted in Around the Market, Contributors | Tagged , , , | Leave a comment